Navigation Links
Reportlinker Adds Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis
Date:5/31/2011

NEW YORK, May 31, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis

http://www.reportlinker.com/p0540675/Global-Top-10-Pharmaceutical-Companies-Industry-Financial-and-SWOT-Analysis.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Musical_I

Introduction

This report forms a part of the Datamonitor's product series titled "Datamonitor Top 10 Industry Players". It aims to provide both quantitative and qualitative analysis to clients on the top 10 pharmaceutical companies' and pharmaceutical industry data and trends across pharmaceutical industry sector.

Scope

* Analyze the global top 10 pharmaceutical companies and the sector overall using key industry metrics and growth forecasts

* Assess the intensity of the competition using the Porter's five forces model, understand the major issues, and predict the key growth areas

* Investigate the top 10 players' SWOT, and access their five-year financial analysis

* Peruse descriptive profiles of the leading players, including details of the strategic initiatives undertaken in the last two years.

Highlights

* The global pharmaceuticals market generated total revenues of $644.2 billion in 2009, representing a compound annual growth rate (CAGR) of 4.3% for the period spanning 2005-09.

* The top 10 global pharmaceutical companies recorded revenues of $361.3 billion during 2009, an increase of 3.7% over 2008. The operating profit of these companies was $84.5 billion during 2009, an increase of 3.6% over 2008. The net profit was $81.3 billion in 2009, an increase of 25% over 2008.

* The average operating profit margin of the top 10 companies slightly declined to 23.2% in 2009 from the previous year's margin of 23.3%. In contrast, the average net profit margin grew to record 26.3% in 2009 as compared with 20.2% in 2008.

Reasons to Purchase

* Sector understanding: develop a detailed understanding of the pharmaceutical industry and identify its top 10 players

* Industry trends and behavior: find out the latest global trends driving the sector with an access to their five-year financial data

* Competitive landscape: obtain information on the sector's top-10 players and understand their key strengths, weaknesses, opportunities and threats

TABLE OF CONTENTS 2

FIGURES 3

Tables 4

Executive Summary 5

Industry analysis 5

Industry definition 5

Research highlights 5

Top 10 companies landscape 6

Market Value 7

Value 7

Market Forecast 8

Forecast 8

Market Segmentation: Product 9

Product 9

Market Segmentation: Geographic 10

Geographic 10

Five Forces Analysis 11

Summary 11

Buyer power 12

Supplier power 13

New entrants 14

Substitutes 15

Rivalry 16

Top 10 Companies Landscape 17

Overview 17

Pfizer 19

F. Hoffmann-La Roche 19

Novartis 19

GlaxoSmithKline 19

Sanofi-Aventis 19

AstraZeneca 19

Abbott Laboratories 20

Merck & Co. 20

Eli Lilly and Company 20

Bristol-Myers Squibb 20

Revenue analysis 21

Financial performance analysis 23

Operating profit analysis 24

Net profit analysis 25

Ratio analysis 26

Current ratio 26

Return on assets (ROA) 26

Debt equity ratio (D/E Ratio) 26

Inventory turnover ratio 27

Company Reports 28

Pfizer 28

Company overview 28

Business description 28

SWOT analysis 29

Strengths 29

Weaknesses 29

Opportunities 30

Threats 31

Recent developments 32

F. Hoffmann-La Roche 34

Company overview 34

Business description 34

SWOT analysis 35

Strengths 35

Weaknesses 36

Opportunities 36

Threats 37

Recent developments 38

Novartis 40

Company overview 40

Business description 40

SWOT analysis 41

Strengths 41

Weaknesses 42

Opportunities 43

Threats 44

Recent developments 45

GlaxoSmithKline 47

Company overview 47

Business description 47

SWOT analysis 49

Strengths 49

Weaknesses 50

Opportunities 51

Threats 53

Recent developments 54

Sanofi-Aventis 56

Company overview 56

Business description 56

SWOT analysis 57

Strengths 57

Weaknesses 59

Opportunities 60

Threats 62

Recent developments 64

AstraZeneca 66

Company overview 66

Business description 66

SWOT analysis 68

Strengths 68

Weaknesses 70

Opportunities 72

Threats 75

Recent developments 77

Abbott Laboratories 79

Company overview 79

Business description 79

SWOT analysis 80

Strengths 80

Weaknesses 82

Opportunities 83

Threats 84

Recent developments 85

Merck & Co. 86

Company overview 86

Business description 86

SWOT analysis 87

Strengths 87

Weaknesses 88

Opportunities 88

Threats 89

Recent developments 90

Eli Lilly and Company 92

Company overview 92

Business description 92

SWOT analysis 94

Strengths 94

Weaknesses 96

Opportunities 97

Threats 99

Recent developments 100

Bristol-Myers Squibb Company 102

Company overview 102

Business description 102

SWOT analysis 103

Strengths 103

Weaknesses 104

Opportunities 105

Threats 106

Recent developments 106

Five-Year Financial Information 108

Pfizer 108

F. Hoffman-La Roche 111

Novartis 114

GlaxoSmithKline 117

Sanofi-Aventis 120

AstraZeneca 123

Abbott Laboratories 126

Merck & Co. 129

Eli Lilly and Company 132

Bristol-Myers Squibb Company 135

Appendix 137

Methodology 137

LIST OF TABLES

Table 1: Global pharmaceutical market ($ billion), 2005-09 7

Table 2: Global pharmaceuticals market forecast ($ billion), 2009-14 8

Table 3: Global pharmaceuticals market segmentation: product (% share), 2009 9

Table 4: Global pharmaceuticals market segmentation: geography (% share), 2009 10

Table 5: Revenues and sales of global top 10 pharmaceutical companies ($m), FY2009 18

Table 6: Revenue growth of global top 10 pharmaceutical companies, FY2007-09 21

Table 7: Key financials of the global top 10 pharmaceutical companies, FY2009 23

Table 8: Key industry-specific ratios, FY2009 26

Table 9: Pfizer: financial and operational highlights, 2005-09 ($m) 108

Table 10: Pfizer: key industry-specific ratios, 2005-09 110

Table 11: F. Hoffman-La Roche: financial and operational highlights, 2005-09 ($m) 111

Table 12: F. Hoffman-La Roche: key industry-specific ratios, 2005-09 113

Table 13: Novartis: financial and operational highlights, 2005-09 ($m) 114

Table 14: Novartis: key industry-specific ratios, 2005-09 116

Table 15: GlaxoSmithKline: financial and operational highlights, 2005-09 ($m) 117

Table 16: GlaxoSmithKline: key industry-specific ratios, 2005-09 119

Table 17: Sanofi-Aventis: financial and operational highlights, 2005-09 ($m) 120

Table 18: Sanofi-Aventis: key industry-specific ratios, 2005-09 122

Table 19: AstraZeneca: financial and operational highlights, 2005-09 ($m) 123

Table 20: AstraZeneca: key industry-specific ratios, 2005-09 125

Table 21: Abbott Laboratories: financial and operational highlights, 2005-09 ($m) 126

Table 22: Abbott Laboratories: key industry-specific ratios, 2005-09 128

Table 23: Merck & Co.: financial and operational highlights, 2005-09 ($m) 129

Table 24: Merck & Co.: key industry-specific ratios, 2005-09 131

Table 25: Eli Lilly and Company: financial and operational highlights, 2005-09 ($m) 132

Table 26: Eli Lilly and Company: key industry-specific ratios, 2005-09 134

Table 27: Bristol-Myers Squibb Company: financial and operational highlights, 2005-09 ($m) 135

Table 28: Bristol-Myers Squibb Company: key industry-specific ratios, 2005-09 136

LIST OF FIGURES

Figure 1: Global pharmaceuticals market ($ billion), 2005-09 7

Figure 2: Global pharmaceuticals market forecast ($ billion), 2009-14 8

Figure 3: Global pharmaceuticals market segmentation: product (% share), 2009 9

Figure 4: Global pharmaceuticals market segmentation: geography (% share), 2009 10

Figure 5: Forces driving competition in the global pharmaceuticals market, 2009 11

Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2009 12

Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2009 13

Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2009 14

Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2009 15

Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2009 16

Figure 11: Revenues of global top 10 pharmaceutical companies ($m), FY2009 18

Figure 12: Revenue growth of the global top 10 pharmaceutical companies, FY2007-09 22

Figure 13: Operating performance analysis, FY2009 24

Figure 14: Net profit analysis, FY2009 25

To order this report:

Musical Instrument Industry: Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis

Musical Instrument Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 2016  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and other birth tissues, human skin and bone, and ... advanced products and therapies, announced today that it will ... Conference in New York , NY.  ... J. Senken , Chief Financial Officer and Chris ...
(Date:2/11/2016)... 11, 2016  AfterPill.com is reporting that this week,s ... for all women who are at risk of unintended ... year and raises the risks of unprotected sex in ... According to the Guttmacher Institute, there are 43 ... child-bearing age, who have sex without the intention of ...
(Date:2/11/2016)... Wearable posture tracker, ALEX , has taken Kickstarter by storm, crowdfunding over $60,000 – or 120% ... ALEX is said to be delivered to backers starting May of this year. ... ... ... Created by NAMU, a team of biomedical engineers out ...
Breaking Medicine Technology:
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Image ... business to a new market, and it’s the buildings of Nashville that will benefit. ... when I needed to relocate to Nashville, there was no question that I would ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... advocates will discuss how to improve care by making data on heart procedures ... disease. The Summit on Transparency and Public Reporting of Pediatric and Congenital Heart ...
(Date:2/11/2016)... Plantation, Fla. (PRWEB) , ... February 11, 2016 ... ... CareTRAK™, an unparalleled clinical decision support technology, with highly adaptable algorithms, has ... cases. When a patient has signs and symptoms consistent with Zikas and a ...
(Date:2/11/2016)... ... February 11, 2016 , ... Life is known for ... men, 60 and older, who gather once a year to play softball to raise ... for the game, the more than 50 players who competed in this year’s softball ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... practice Village Family Practice , will be presenting at the 2016 HIMSS ... Las Vegas, Nev. , During his session, “ Coding for Care: Using ...
Breaking Medicine News(10 mins):